UiPath's strategy reflects a company that's no longer chasing automation hype -- it's laying the groundwork for durable, ...
Zacks Investment Research on MSN
Here's Why UiPath (PATH) Fell More Than Broader Market
UiPath (PATH) closed at $14.27 in the latest trading session, marking a -10.08% move from the prior day. This change lagged the S&P 500's daily loss of 1.17%. At the same time, the Dow lost 0.53%, and ...
VIAVI Takes First Place at CHALLENGE.GOV Electronic Warfare (EW) Battlefield Realism Prize Challenge
T/Rx Software Defined Transceiver System has been awarded first place in the CHALLENGE.GOV Electronic Warfare (EW) Battlefield Realism Prize Challenge at Camp Shelby, Mississippi. During the challenge ...
Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
Zacks Investment Research on MSN
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback